Navigation Links
Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Date:9/4/2007

are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that required clinical trials will be successful, necessary regulatory approvals will be obtained, or the proposed treatments will prove to be safe or effective. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, our limited experience in the development of therapeutic drugs, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on research grants, current and future competition, and other risks described from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Contact:

Scott Pancoast Investor Relations

(858) 678-0800 x104 Liolios Group, Inc.

spancoast@Lpath.com Scott Liolios or Ron Both

http://www.Lpath.com (949) 574-3860


'/>"/>
SOURCE Lpath, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lpath Demonstrates First-in-Class AMD Results With Its Lead Drug Candidate, Sphingomab
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
7. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
8. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
9. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... LOS ANGELES , Nov. 28, 2014 According ... Americans over the course of their lifetime. For many, these ... chronic pain that is caused by a variety of factors. ... disc, surgery may be the best option. While there are ... Laser Discectomy performed by Seyed M. Rezaian , M.D., ...
(Date:11/28/2014)... Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... acquisition, development and commercialization of innovative biopharmaceutical products for ... it will present at the 26 th Annual ... 2014, at the New York Palace Hotel in ... St. Peter , M.D., President and Chief Executive Officer, ...
(Date:11/27/2014)...  Javon Bea Mercy Health System President ... at Janesville Craig High School and Janesville Parker High ... physicians and Janesville Police and ... Janesville School District. The event ... providing schools and other organizations with the resources needed ...
Breaking Medicine Technology:4 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3
... COPENHAGEN, November 2 Nuevolution ... derived from its collaboration with,Merck & Co. Inc., Whitehouse ... was triggered following identification of several candidate,molecules that conformed ... original agreement. These include several accepted drug-like,characteristics and nanomolar ...
... In a randomized, double-blind, placebo-controlled trial of 247 patients who ... and liver enzymes; however, vitamin E was more successful for ... associated with fatty liver disease, insulin resistance, and obesity, and ... have NASH. The disease progresses to inflammation in the liver ...
Cached Medicine Technology:Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc. 2Vitamin E Improves NASH 2
(Date:11/29/2014)... Syntermed, Inc. announces availability for its ... for the U.S. nuclear medicine market at the ... , “NeuroQ is well established and being ... of PET- FDG and Amyloid brain imaging studies, ... Michael Lee, CEO, Syntermed, Inc. “Radiologists and their departments ...
(Date:11/28/2014)... 2014 The emerging blend ... research in all the healthcare segments such ... support and population health management. The demand ... innovation in machine learning, logical methodologies, computational ... full report with full table of contents ...
(Date:11/28/2014)... November 29, 2014 The report ... information on the therapeutic development for Poxvirus Infections, ... assessment by drug target, mechanism of action (MoA), ... with latest updates, and featured news and press ... the therapeutic development for Poxvirus Infections and special ...
(Date:11/28/2014)... PrettyTailor.com has developed and created its new collection of ... in celebration of the coming holiday season. To show ... offer on all these outfits. Click here ... garment industry, PrettyTailor.com brings together art and technology to ... business carries quite a few in eye-catching patterns for ...
(Date:11/28/2014)... 29, 2014 The holiday season is fast ... announced its new collection of fashionable party dresses. What’s more, ... on all these brand new outfits; the special offer is ... a renowned online supplier and it has received a lot ... items are specially designed to flatter various body shapes; they ...
Breaking Medicine News(10 mins):Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 2Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 3Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2
... ... Thomas A. Einhorn Advances Safe and Successful Adult Stem Cell Therapy To Eliminate Hip ... ... A. Einhorn , internationally renowned Orthopaedic Surgeon and Chairman of the Department of Orthopaedic ...
... Members ... , ... 2010 -- With summer just around the corner, many people are hoping to tone up in ... Predicto Mobile community to ponder some weighty issues this spring. Members of Snackable ...
... a world first study of its kind, 161 postnatal ... two separate groups to test the effect of a ... The experimental group received an eight-week "Mother and Baby" ... physiotherapist combined with parenting education. In the ...
... loss, metastasis, study finds , WEDNESDAY, March 31 ... (Zometa) reduces the spread of breast cancer by ... , Tumor cells released from the primary breast ... and spread from there to other areas of ...
... slash youngsters, consumption, study finds , THURSDAY, April 1 (HealthDay ... soda consumption, a new study finds. , Although taxes ... efforts to fight childhood obesity, they may have to be ... is to noticeably reduce soda consumption among children, then it ...
... for Art & Healing today releases the proceedings from its ... luminaries from the medical, arts and public health sectors regarding ... during the summer of 2009 in New York, the goal ... expertise as well as the direct experiences of cardiac patients ...
Cached Medicine News:Health News:Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery 2Health News:Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery 3Health News:Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery 4Health News:Predicto Mobile Community Weighs in on Celebrity Weight Loss 2Health News:Predicto Mobile Community Weighs in on Celebrity Weight Loss 3Health News:New mums beat the blues and increase wellbeing with physio exercise, study reveals 2Health News:Bone-Strengthening Drug Guards Against Spread of Breast Cancer 2Health News:Small Tax on Soda Won't Curb Child Obesity 2Health News:The creative engagement and cardiac health connection disclosed 2Health News:The creative engagement and cardiac health connection disclosed 3
... with astigmatism. , If you have astigmatism, ... enjoy a level of comfort unrivaled by ... especially notice the longer you wear your ... of comfort is made possible by PC ...
... lens convenience for those with astigmatism , ... clear vision with the convenience of a ... lenses are manufactured using our patented UltraSync® ... edge on every lens. This lens design ...
The Heine C series binocular loupes offer extremely low weight (46 g), crisp views, and quality German construction in an affordable instrument....
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work....
Medicine Products: